Literature DB >> 24192942

Systematic analysis underlying the quality of the scientific evidence and conflicts of interest in gastroenterology practice guidelines.

Joseph D Feuerstein1, Anne E Gifford, Mona Akbari, Jonathan Goldman, Daniel A Leffler, Sunil G Sheth, Adam S Cheifetz.   

Abstract

OBJECTIVES: The practice guidelines published by the American Gastroenterological Association (AGA) and the American College of Gastroenterology (ACG) are used to establish standards of care and improve patient outcomes. We examined the guidelines for quality of evidence, methods of grading evidence, and conflicts of interest (COIs).
METHODS: All 81 (AGA and ACG) guidelines available online on 26 July 2012 were reviewed for the presence of grading of evidence and COIs. In total, 570 recommendations were evaluated for level of evidence and methods used to grade the evidence. The data were evaluated in aggregate and by society.
RESULTS: Only 31% (n=25) of the guidelines graded the levels of evidence. A total of 12 systems were used to grade the quality of evidence in these 25 guidelines. Of the 570 recommendations reviewed, only 29% (n=165) were supported by the highest quality of evidence, level A; 37% (n=210) level B, 29% (n=165) level C, and 5% (n=30) level D. Since 2007, 87% (n=13/15) of the ACG guidelines graded the evidence compared with only 33% of the AGA guidelines (n=4/12). Furthermore, 70% (n=57/81) of the guidelines failed to disclose any information regarding COIs. Of the 24 articles commenting on COIs, 67% reported COIs.
CONCLUSIONS: Although the majority of the gastroenterology guidelines fail to grade the quality of evidence, more recent ACG guidelines grade majority of their recommendations. When the evidence is graded, most of the supporting evidence is based on lower-quality evidence. In addition, most of the guidelines fail to comment on COIs, and when disclosed, numerous COIs were present. This study highlights the critical need to revise the guideline development process. Future guidelines should clearly state the quality of evidence for their recommendations, utilize a standard grading system, and be transparent regarding all COIs.

Entities:  

Mesh:

Year:  2013        PMID: 24192942     DOI: 10.1038/ajg.2013.150

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  11 in total

1.  The Diagnosis, Prognosis, and Treatment of Medical Uncertainty.

Authors:  Charlie M Wray; Lawrence K Loo
Journal:  J Grad Med Educ       Date:  2015-12

2.  Evidence Underlying Recommendations and Payments from Industry to Authors of the National Comprehensive Cancer Network Guidelines.

Authors:  Xu Liu; Ling-Long Tang; Yan-Ping Mao; Qing Liu; Ying Sun; Lei Chen; Jin-Ching Lin; Jun Ma
Journal:  Oncologist       Date:  2018-11-20

Review 3.  Systematic Analysis and Critical Appraisal of the Quality of the Scientific Evidence and Conflicts of Interest in Practice Guidelines (2005-2013) for Barrett's Esophagus.

Authors:  Joseph D Feuerstein; Natalia E Castillo; Mona Akbari; Edward Belkin; Jeffrey J Lewandowski; Christine M Hurley; Samuel Lloyd; Daniel A Leffler; Adam S Cheifetz
Journal:  Dig Dis Sci       Date:  2016-06-15       Impact factor: 3.199

4.  Multicenter Study Assessing Physician Recommendations Regarding the Continuation of Aspirin and/or NSAIDs Prior to Gastrointestinal Endoscopy.

Authors:  Joseph D Feuerstein; Elliot B Tapper; Edward Belkin; Jeffrey J Lewandowski; Anand Singla; Saurabh Sethi; Sunil G Sheth; Mandeep Sawheny
Journal:  Dig Dis Sci       Date:  2015-06-30       Impact factor: 3.199

5.  Evaluation of Conflicts of Interest among Participants of the Japanese Nephrology Clinical Practice Guideline.

Authors:  Anju Murayama; Kohki Yamada; Makoto Yoshida; Yudai Kaneda; Hiroaki Saito; Toyoaki Sawano; Sunil Shrestha; Rajeev Shrestha; Tetsuya Tanimoto; Akihiko Ozaki
Journal:  Clin J Am Soc Nephrol       Date:  2022-06       Impact factor: 10.614

6.  Guidelines in Gastroenterology: Careful Interpretation Is Essential.

Authors:  Catarina Correia; Nuno Almeida; Pedro Narra Figueiredo
Journal:  GE Port J Gastroenterol       Date:  2021-08-25

7.  Appraising the Evidence Supporting Choosing Wisely® Recommendations.

Authors:  Andrew J Admon; Ashwin Gupta; Margaret Williams; Thomas S Valley; Michael W Sjoding; Renda Soylemez Wiener; Colin R Cooke
Journal:  J Hosp Med       Date:  2018-04-25       Impact factor: 2.960

Review 8.  Financial Conflicts of Interest in Clinical Practice Guidelines: A Systematic Review.

Authors:  Sahar Tabatabavakili; Rishad Khan; Michael A Scaffidi; Nikko Gimpaya; David Lightfoot; Samir C Grover
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-01-19

Review 9.  Methodological Reporting Quality of Randomized Controlled Trials in 3 Leading Diabetes Journals From 2011 to 2013 Following CONSORT Statement: A System Review.

Authors:  Xiao Zhai; Yiran Wang; Qingchun Mu; Xiao Chen; Qin Huang; Qijin Wang; Ming Li
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

10.  Guideline appraisal with AGREE II: online survey of the potential influence of AGREE II items on overall assessment of guideline quality and recommendation for use.

Authors:  Wiebke Hoffmann-Eßer; Ulrich Siering; Edmund A M Neugebauer; Anne Catharina Brockhaus; Natalie McGauran; Michaela Eikermann
Journal:  BMC Health Serv Res       Date:  2018-02-27       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.